Safety and Efficacy of Indacaterol Once Daily Versus Salmeterol Twice Daily in Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study compared the safety and efficacy of indacaterol 150 µg taken once daily (o.d.)
versus salmeterol 50 µg taken twice daily (b.i.d) in patients 40 years old or older with
chronic obstructive pulmonary disease.